Yang; Eun Ji

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yang; Eun Ji.The latest application filed is for "pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative ".

Company Profile

4.6.9

Yang; Eun Ji - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
MTOR/STAT3 signal inhibitor-treated mesenchymal stem cell having immunomodulatory activity, and cell therapy composition comprising same, for preventing or treating immune disorders Grant 10,851,346 - Yang , et al. December 1, 2	2020-12-01
Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient Grant 10,716,771 - Cho , et al.	2020-07-21
Pharmaceutical Composition For Preventing Or Treating Immune Diseases Or Inflammatory Diseases, Containing Biguanide Derivative App 20190328685 - Cho; Mi-La ; et al.	2019-10-31
Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient Grant 10,369,121 - Cho , et al.	2019-08-06
Pharmaceutical Composition For Preventing Or Treating Immune Diseases Or Inflammatory Diseases, Containing Biguanide Derivative Compound As Active Ingredient App 20170333370 - CHO; Mi-La ; et al.	2017-11-23
Composition comprising metformin as active ingredient for preventing or treating inflammatory bowel disease Grant 9,700,531 - Cho , et al. July 11, 2	2017-07-11
Composition Using Metformin For Preventing Or Treating Immune Diseases Including Lupus App 20170157069 - CHO; Mi-La ; et al.	2017-06-08
Composition for preventing or treating autoimmune disease, comprising, as active ingredient, PINK1 protein or polynucleotide encoding same Grant 9,585,945 - Cho , et al. March 7, 2	2017-03-07
Composition for treating immune diseases containing daurinol compound as active ingredient Grant 9,526,717 - Cho , et al. December 27, 2	2016-12-27
Mtor/stat3 Signal Inhibitor-treated Mesenchymal Stem Cell Having Immunomodulatory Activity, And Cell Therapy Composition Comprising Same, For Preventing Or Treating Immune Disorders App 20160289640 - YANG; Chul Woo ; et al.	2016-10-06
Composition For Preventing And Treating Immune Diseases Containing Daurinol Compound As Active Ingredient App 20160193180 - CHO; Mi-La ; et al.	2016-07-07
Composition For Preventing Or Treating Autoimmune Disease, Comprising, As Active Ingredient, Pink1 Protein Or Polynucleotide Encoding Same App 20160114007 - Cho; Mi-La ; et al.	2016-04-28
Composition Comprising Grim-19 As Active Ingredient For Preventing Or Treating Obesity Or Lipid-related Metabolic Diseases App 20150297676 - CHO; Mi-La ; et al.	2015-10-22
Composition Using Metformin For Preventing Or Treating Immune Diseases Including Lupus App 20150238445 - Cho; Mi-La ; et al.	2015-08-27
Composition Comprising Metformin As Active Ingredient For Preventing Or Treating Inflammatory Bowel Disease App 20150196511 - Cho; Mi-La ; et al.	2015-07-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.